Dacarbazine
CAS Number
4342-03-4Synonym
DIC; (Dimethyltriazeno)imidazolecarboxamide) DTIC; NCI-C04717; NSC-45388; 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
Occurrence/Use
Medicine (antineoplastic)
| Latest Criteria: |
Proposition 65 NSRLs/MADLs
|
|---|---|
| Inhalation Unit Risk (μg/cubic meter)-1: |
1.4 E-2
|
| Inhalation Slope Factor (mg/kg-day)-1: |
4.9 E+1
|
| Oral Slope Factor (mg/kg-day)-1: |
4.9 E+1
|
| Comments/References: |
Proposition 65
| Cancer: |
Currently listed
|
|---|---|
| Reproductive Toxicity: |
Currently listed
|
| Listed for: |
Cancer
|
|---|---|
| Date of Listing: |
01/01/1988
|
| Basis for Listing: |
State's Qualified Experts
|
| Listed for: |
Developmental Toxicity
|
|---|---|
| Developmental Toxicity | |
| Date of Listing: |
01/29/1999
|
| Basis for Listing: |
Formally Required
|
| Cancer | |
| No Significant Risk Level (NSRL): |
0.01 µg/day
|
|---|---|
| Last NSRL/MADL Revision: |
1992
|
| Cancer: | |
|---|---|
| Reproductive Toxicity: |
